Bolt Biotherapeutics Aktie - BOLT

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

0,60

Gebot

0,561

Fragen

0,60

Volumen

261.425

0,56 Tagesbereich 0,5975

0,475 52-Wochen-Bereich 1,56

Marktkapitalisierung

22,964M

Handelsende

0,57

Handelsbeginn

0,57

Letzte Trade

250

0.6

(formt)

Letzter Handelszeitpunkt

Finanzvolumen

US$ 153.547

VWAP

0,587346

Durchschnittliches Volumen (3 Mio.)

155.535

Ausgegebene Aktien

38.273.002

Dividendenrendite

Kurs-Gewinn-Verhältnis

-0,32

Gewinn pro Aktie (EPS)

-1,81

Erlöse

7,88M

Nettogewinn

-69,2M

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.boltbio.com

Hauptsitz

Dover, Delaware, USA

Gegründet

Bolt Biotherapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BOLT. The last closing price for Bolt Biotherapeutics was US$0,57. Over the last year, Bolt Biotherapeutics shares have traded in a share price range of US$ 0,475 to US$ 1,56.

Bolt Biotherapeutics currently has 38.273.002 shares in issue. The market capitalisation of Bolt Biotherapeutics is US$21,82 million. Bolt Biotherapeutics has a price to earnings ratio (PE ratio) of -0.32.

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Advanced to the highest dose level in the Phase 1 dose-escalation clinical study of BDC-3042 in patients with advanced cancersPresented updated preclinical activity of BDC-4182 and key learnings...

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

BDC-4182 demonstrated compelling anti-tumor activity and an acceptable safety profile in preclinical studies BDC-4182 outperformed cytotoxic claudin 18.2 ADCs in syngeneic model Learnings from...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.099	19.7604790419	0.501	0.6	0.496	278405	0.5520149	CS
4	0.008	1.35135135135	0.592	0.606299	0.475	211797	0.53543388	CS
12	-0.04	-6.25	0.64	0.718	0.475	155535	0.5853165	CS
26	-0.1326	-18.0999180999	0.7326	0.78	0.475	160991	0.64121553	CS
52	-0.54	-47.3684210526	1.14	1.56	0.475	167062	0.82433051	CS
156	-4.27	-87.6796714579	4.87	4.99	0.475	187780	1.52935434	CS
260	-21.39	-97.2714870396	21.99	43.07	0.475	190294	6.50852932	CS

BOLT - Frequently Asked Questions (FAQ)

What is the current Bolt Biotherapeutics share price?

The current share price of Bolt Biotherapeutics is US$ 0,60

How many Bolt Biotherapeutics shares are in issue?

Bolt Biotherapeutics has 38.273.002 shares in issue

What is the market cap of Bolt Biotherapeutics?

The market capitalisation of Bolt Biotherapeutics is USD 21,82M

What is the 1 year trading range for Bolt Biotherapeutics share price?

Bolt Biotherapeutics has traded in the range of US$ 0,475 to US$ 1,56 during the past year

What is the PE ratio of Bolt Biotherapeutics?

The price to earnings ratio of Bolt Biotherapeutics is -0,32

What is the cash to sales ratio of Bolt Biotherapeutics?

The cash to sales ratio of Bolt Biotherapeutics is 2,82

What is the reporting currency for Bolt Biotherapeutics?

Bolt Biotherapeutics reports financial results in USD

What is the latest annual turnover for Bolt Biotherapeutics?

The latest annual turnover of Bolt Biotherapeutics is USD 7,88M

What is the latest annual profit for Bolt Biotherapeutics?

The latest annual profit of Bolt Biotherapeutics is USD -69,2M

What is the registered address of Bolt Biotherapeutics?

The registered address for Bolt Biotherapeutics is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901

What is the Bolt Biotherapeutics website address?

The website address for Bolt Biotherapeutics is www.boltbio.com

Which industry sector does Bolt Biotherapeutics operate in?

Bolt Biotherapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
FCUVFocus Universal Inc	US$ 0,9499 (174,93%)	260,93M
NITON2OFF Inc	US$ 2,6306 (145,85%)	358,28M
CRNCCerence Inc	US$ 19,33 (143,76%)	161,8M
KITTNauticus Robotics Inc	US$ 3,8249 (140,56%)	104,8M
ACONAclarion Inc	US$ 0,2984 (110,14%)	305,64M
HWHHWH International Inc	US$ 0,4621 (-28,80%)	7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF	US$ 5,69 (-26,30%)	24,77M
RAINRain Enhancement Technologies Holdco Inc	US$ 5,59 (-23,42%)	161,15k
PTLEPTL Ltd	US$ 9,35 (-23,30%)	1,04M
NXUNXU Inc	US$ 0,725868 (-22,78%)	7,59M
NITON2OFF Inc	US$ 2,6306 (145,85%)	350,92M
TGLTreasure Global Inc	US$ 0,382 (101,58%)	330,82M
ACONAclarion Inc	US$ 0,2984 (110,14%)	305,59M
FCUVFocus Universal Inc	US$ 0,9499 (174,93%)	259,78M
NVDANVIDIA Corporation	US$ 144,47 (4,45%)	222,72M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Bolt Biotherapeutics Inc (BOLT) Börsenkurse

Bolt Biotherapeutics Inc (BOLT)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Bolt Biotherapeutics Inc

BOLT Neueste Nachrichten

BOLT - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen